Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Marginally Lower After Paring Losses

11/24/2021 | 01:36pm EST


ę MT Newswires 2021
All news about GUARDANT HEALTH, INC.
01/19Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy ..
BU
01/19Guardant Health to Present Data Highlighting the Clinical Utility of Its Liquid Biopsy ..
CI
01/18Guardant Health Enrolls First Patient in Blood Test Study to Detect Lung Cancer in High..
MT
01/18Guardant Health Enrolls First Patient in SHIELD LUNG Study to Evaluate Accuracy of Its ..
BU
01/18Guardant Health, Inc. Enrolls First Patient in SHIELD LUNG Study to Evaluate Accuracy o..
CI
01/12INSIDER SELL : Guardant Health
MT
01/10GUARDANT HEALTH : J.P. Morgan Healthcare Conference Presentation
PU
01/07GUARDANT HEALTH : and Foundation Medicine Reach Settlement in Digital Sequencing Technolog..
PU
01/07GUARDANT HEALTH, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/07Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technolo..
BU
More news
Analyst Recommendations on GUARDANT HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 365 M - -
Net income 2021 -445 M - -
Net cash 2021 80,5 M - -
P/E ratio 2021 -14,3x
Yield 2021 -
Capitalization 6 379 M 6 379 M -
EV / Sales 2021 17,3x
EV / Sales 2022 14,3x
Nbr of Employees 864
Free-Float -
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 62,75 $
Average target price 160,17 $
Spread / Average Target 155%
EPS Revisions
Managers and Directors
Helmy Eltoukhy Chairman & Co-Chief Executive Officer
AmirAli H. Talasaz President, Co-Chief Executive Officer & Director
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capi. (M$)
GUARDANT HEALTH, INC.-37.26%6 261
EXACT SCIENCES CORPORATION-9.83%11 874
BGI GENOMICS CO., LTD.-4.33%5 357
SEEGENE, INC.-10.82%2 255
INVITAE CORPORATION-33.07%2 191
IOVANCE BIOTHERAPEUTICS, INC.-21.22%2 170